Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PLERIXAFOR for Peripheral blood stem cell apheresis: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 9 adverse event reports in the FDA FAERS database where PLERIXAFOR was used for Peripheral blood stem cell apheresis.

Most Reported Side Effects for PLERIXAFOR

Side Effect Reports % Deaths Hosp.
Febrile neutropenia 69 15.4% 13 18
Mucosal inflammation 47 10.5% 6 3
Nausea 29 6.5% 2 11
Off label use 29 6.5% 4 4
Dyspnoea 28 6.3% 1 19
Pyrexia 27 6.0% 6 16
Diarrhoea 24 5.4% 7 6
Thrombocytopenia 23 5.2% 2 6
Acute kidney injury 21 4.7% 2 18
Acute respiratory distress syndrome 20 4.5% 3 17
Escherichia infection 18 4.0% 6 11
Alanine aminotransferase increased 17 3.8% 1 16
Colitis 17 3.8% 0 16
Herpes simplex 17 3.8% 3 0
Stomatitis 17 3.8% 1 2

Other Indications for PLERIXAFOR

Haematopoietic stem cell mobilisation (151) Plasma cell myeloma (30) Bone marrow conditioning regimen (21) Diffuse large b-cell lymphoma (17) Product used for unknown indication (17) Transplant (16) Acute myeloid leukaemia (13) Stem cell transplant (11) Non-hodgkin's lymphoma (9) Combined immunodeficiency (8)

Other Drugs Used for Peripheral blood stem cell apheresis

FILGRASTIM (80) GRANULOCYTE COLONY-STIMULATING FACTOR NOS (66) PEGFILGRASTIM (26) NEUPOGEN (21) G-CSF (16)

Related Pages

PLERIXAFOR Full Profile All Peripheral blood stem cell apheresis Drugs PLERIXAFOR Demographics PLERIXAFOR Timeline